Re: As Pfizer charges ahead....
in response to
by
posted on
Sep 03, 2021 06:23PM
I'm beginning to worry that RVX might be being priced out of starting the trial. Clinical centers often agree to participate in clinical trials on a per patient funding basis. So they get paid a negotiated amount (agreed in advance) for each patient recruited and completed. As BP can afford to pay more per patient, RVX might have to wait a long time!